Revisiting and questioning functional rescue between dimerized LH receptor mutants

Molecular Endocrinology

Volumn 26, Issue 4, 2012, Pages 655-668

  Zhang, Meilin ^a   Guan, Rongbin ^a   Segaloff, Deborah L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE RECEPTOR; MUTANT PROTEIN;

ARTICLE; DIMERIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CHORIONIC GONADOTROPIN; CYCLIC AMP; HEK293 CELLS; HUMANS; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; RECEPTORS, LH; SECOND MESSENGER SYSTEMS;

EID: 84859116629     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1285     Document Type: Article

References (54)

1. Xie YB, Wang H, Segaloff DL 1990 Extracellular domain of lutropin/ choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem 265: 21411-21414
2. Davis D, Liu X, Segaloff DL 1995 Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 9:159-170
3. Thomas D, Rozell TG, Liu X, Segaloff DL 1996 Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding. Mol Endocrinol 10:760-768
4. Fan QR, Hendrickson WA 2005 Structure of human folliclestimulating hormone in complex with its receptor. Nature 433: 269-277
5. Tao YX, Johnson NB, Segaloff DL 2004 Constitutive and agonistdependent self-association of the cell surface human lutropin receptor. J Biol Chem 279:5904-5914
6. Guan R, Feng X, Wu X, Zhang M, Zhang X, Hébert TE, Segaloff DL 2009 Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J Biol Chem 284:7483-7494
7. Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S 2005 Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24:1954-1964
8. Ji I, Lee C, Song Y, Conn PM, Ji TH 2002 Cis-and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol 16:1299-1308
9. Lee C, Ji I, Ryu K, Song Y, Conn PM, Ji TH 2002 Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chem 277:15795-15800
10. Jeoung M, Lee C, Ji I, Ji TH 2007 Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol Cell Endocrinol 260-262:137-143
11. Rivero-Müller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, Huhtaniemi I 2010 Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA 107:2319-2324
12. Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, Blomberg L, Cutler Jr GB 1995 Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 92:1906-1910
13. Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler Jr GB, Jelly DH, Diamond FB, Chan WY 1996 Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. Biochem Mol Med 58:192-198
14. Kremer H, Martens JW, van Reen M, Verhoef-Post M, Wit JM, Otten BJ, Drop SL, Delemarre-van de Waal HA, Pombo-Arias M, De Luca F, Potau N, Buckler JM, Jansen M, Parks JS, Latif HA, Moll GW, Epping W, Saggese G, Mariman EC, Themmen AP, Brunner HG 1999 A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 84:1136-1140
15. Latronico AC, Abell AN, Arnhold IJ, Liu X, Lins TS, Brito VN, Billerbeck AE, Segaloff DL, Mendonca BB 1998 A unique constitutively activating mutation in the third transmembrane helix of the luteinizing hormone receptor causes sporadic male gonadotropin independent precocious puberty. J Clin Endocrinol Metab 83: 2435-2440
16. Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL 1998 A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expresssion and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-450
17. Hirakawa T, Galet C, Ascoli M 2002 MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR. Endocrinology 143:1026-1035
18. Hirakawa T, Ascoli M 2003 A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia. Endocrinology 144:3872-3878
19. Qiao J, Han B, Liu BL, Chen X, Ru Y, Cheng KX, Chen FG, Zhao SX, Liang J, Lu YL, Tang JF, Wu YX, Wu WL, Chen JL, Chen MD, Song HD 2009 A splice site mutation combined with a novel missense mutation of LHCGR cause male pseudohermaphroditism. Hum Mutat 30:E855-E865
20. Richter-Unruh A, Martens JW, Verhoef-Post M, Wessels HT, Kors WA, Sinnecker GH, Boehmer A, Drop SL, Toledo SP, Brunner HG, Themmen AP 2002 Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf) 56:103-112
21. Wu SM, Hallermeier KM, Laue L, Brain C, Berry AC, Grant DB, Griffin JE, Wilson JD, Cutler Jr GB, Chan WY 1998 Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12: 1651-1660
22. Martens JW, Verhoef-Post M, Abelin N, Ezabella M, Toledo SP, Brunner HG, Themmen AP 1998 A homozygous mutation of the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12:775-784
23. Toledo SP, Brunner HG, Kraaij R, Post M, Dahia PL, Hayashida CY, Kremer H, Themmen AP 1996 An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female. J Clin Endocrinol Metab 81:3850-3854
24. Kremer H, Kraaij R, Toledo SP, Post M, Fridman JB, Hayashida CY, van Reen M, Milgrom E, Ropers HH, Mariman E, Themmen APN, Brunner HG 1995 Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160-164
25. Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler Jr GB, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB, Chan WY 1995 A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 4:1429-1433
26. Zhang M, Mizrachi D, Fanelli F, Segaloff DL 2005 The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the natu-rally occurring L457R mutation of the human lutropin receptor. J Biol Chem 280:26169-26176
27. Zhang M, Tao YX, Ryan GL, Feng X, Fanelli F, Segaloff DL 2007 Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem 282:25527-25539
28. Zhang M, Feng X, Guan R, Hébert TE, Segaloff DL 2009 A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization. Cell Signal 21:1663-1671
29. Hébert TE, Galés C, Rebois RV 2006 Detecting and imaging protein-protein interactions during G protein-mediated signal transduction in vivo and in situ by using fluorescence-based techniques. Cell Biochem Biophys 45:85-109
30. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M 2002 Quantitative assessment of β 1-and β 2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931
31. Pfleger KD, Eidne KA 2006 Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3:165-174
32. Thomas RM, Nechamen CA, Mazurkiewicz JE, Muda M, Palmer S, Dias JA 2007 Follicle-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology 148:1987-1995
33. Guan R, Wu X, Feng X, Zhang M, Hébert TE, Segaloff DL 2010 Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell Signal 22:247-256
34. Latronico AC, Segaloff DL 1999 Naturally occurring mutations of the luteinizing hormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 65:949-958
35. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583
36. Shenker A, Laue L, Kosugi S, Merendino Jr JJ, Minegishi T, Cutler Jr GB 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365: 652-654
37. Chandler KJ, Chandler RL, Broeckelmann EM, Hou Y, Southard-Smith EM, Mortlock DP 2007 Relevance of BAC transgene copy number in mice: transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mamm Genome 18:693-708
38. Milligan G 2008 A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br J Pharmacol 153(Suppl 1):S216-S229
39. Terrillon S, Bouvier M 2004 Roles of G-protein-coupled receptor dimerization. EMBO Rep 5:30-34
40. Dalrymple MB, Pfleger KD, Eidne KA 2008 G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther 118:359-371
41. Palczewski K 2010 Oligomeric forms of G protein-coupled receptors (GPCRs). Trends Biochem Sci 35:595-600
42. Damian M, Martin A, Mesnier D, Pin JP, Banères JL 2006 Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J 25:5693-5702
43. Damian M, Mary S, Martin A, Pin JP, Banères JL 2008 G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation. J Biol Chem 283:21084-21092
44. Jastrzebska B, Fotiadis D, Jang GF, Stenkamp RE, Engel A, Palczewski K 2006 Functional and structural characterization of rhodopsin oligomers. J Biol Chem 281:11917-11922
45. Park PS, Lodowski DT, Palczewski K 2008 Activation ofGproteincoupled receptors: beyond two-state models and tertiary conformational changes. Annu Rev Pharmacol Toxicol 48:107-141
46. Hlavackova V, Goudet C, Kniazeff J, Zikova A, Maurel D, Vol C, Trojanova J, Prézeau L, Pin JP, Blahos J 2005 Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J 24:499-509
47. Han Y, Moreira IS, Urizar E, Weinstein H, Javitch JA 2009 Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 5:688-695
48. Sohy D, Yano H, de Nadai P, Urizar E, Guillabert A, Javitch JA, Parmentier M, Springael JY 2009 Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J Biol Chem 284:31270-31279
49. Monnier C, Tu H, Bourrier E, Vol C, Lamarque L, Trinquet E, Pin JP, Rondard P 2011 Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation. EMBO J 30:32-42
50. Ascoli M, Puett D 1978 Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells. Proc Natl Acad Sci USA 75: 99-102
51. Mizrachi D, Segaloff DL 2004 Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors. Mol Endocrinol 18:1768-1777
52. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T) method. Methods 25:402-408
53. Schmittgen TD, Zakrajsek BA 2000 Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 46:69-81
54. Yamashita S, Tai P, Charron J, Ko C, Ascoli M 2011 The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility. Mol Endocrinol 25: 1211-1222